Ciprofloxacin versus Aminoglycoside–Ciprofloxacin for Bubonic Plague

Authors: Randremanana, Rindra Vatosoa, Raberahona, Mihaja, Bourner, Josephine, Rajerison, Minoarisoa, Edwards, Tansy, Randriamparany, Ravaka, Razafindratsinana, Tsinjo Fehizoro, Razananaivo, Lisy Hanitra, Zadonirina, Gabriella, Mayouya-Gamana, Théodora, Salam, Alex Paddy Abdel, Mangahasimbola, Reziky Tiandraza, Andrianaivoarimanana, Voahangy, Pesonel, Elise, Rakotoarivelo, Rivonirina Andry, Randria, Mamy Jean de Dieu, Horby, Peter, Olliaro, Piero, IMASOY Study Group

Contributors: Group, IMASOY Study, Calmy, Alexandra

Source: New England Journal of Medicine. 393:544-555

Subject Terms: Gentamicins / adverse effects, Adult, Male, Yersinia pestis / drug effects, Adolescent, Yersinia pestis, Administration, Oral, Injections, Intramuscular, Drug Therapy, Combination / methods, Drug Therapy, Combination / adverse effects, Young Adult, Aminoglycosides / adverse effects, Yersinia pestis / isolation & purification, Ciprofloxacin, Ciprofloxacin / administration & dosage, Madagascar, Humans, Treatment Failure, Infusions, Intravenous, Child, Anti-Bacterial Agents / adverse effects, Aged, Plague, Plague / drug therapy, Madagascar / epidemiology, Middle Aged, Streptomycin / administration & dosage, Aminoglycosides / administration & dosage, Anti-Bacterial Agents, Drug Combinations, Aminoglycosides, Gentamicins / administration & dosage, Anti-Bacterial Agents / administration & dosage, Plague / diagnosis, Child, Preschool, Ciprofloxacin / adverse effects, Plague / mortality, Female, Drug Therapy, Combination, Streptomycin / adverse effects

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40768716
https://ora.ox.ac.uk/objects/uuid:810d2d46-0a1d-419a-808e-196d1b4c1314
https://doi.org/10.1056/nejmoa2413772

Combinaison thérapeutique innovante pour le diabète type 2 à risque cardiorénal

Authors: Scheen, André, Paquot, Nicolas

Source: Revue Médicale Suisse. 20:1492-1497

Subject Terms: Drug Therapy, Combination/methods, Urologie & néphrologie, Pharmacie, pharmacologie & toxicologie, Systèmes cardiovasculaire & respiratoire, Sciences de la santé humaine, Glucagon-Like Peptide-1 Receptor, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage/therapeutic use, Endocrinology, metabolism & nutrition, Cardiovascular & respiratory systems, Hypoglycemic Agents, Humans, Glucagon-Like Peptide-1 Receptor/agonists, Diabetes Mellitus, Type 2/drug therapy/complications, Urology & nephrology, Hypoglycemic Agents/administration & dosage/therapeutic use, Human health sciences, Sodium-Glucose Transporter 2 Inhibitors, Cardiovascular Diseases/prevention & control, Pharmacy, pharmacology & toxicology, Endocrinologie, métabolisme & nutrition

Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow‐up: results from a large cohort of patients with long follow-up

Authors: Nicholas Schreck, Carsten Müller-Tidow, Marco Basset, Dirk Hose, Tobias Dittrich, Axel Benner, Stefan Schönland, Julia Krzykalla, Anja Seckinger, Hartmut Goldschmidt, Kaya Veelken, Anna Jauch, Ute Hegenbart, Christoph Kimmich

Contributors: FORMER_Hematology, Basic (bio-) Medical Sciences

Source: British Journal of Haematology. 195:230-243

Subject Terms: Dexamethasone/administration & dosage, Peptide Fragments/metabolism, Adult, Male, Antineoplastic Agents, Hormonal, Drug Therapy, Combination/methods, Immunoglobulin Light-chain Amyloidosis/diagnosis, Biomarkers/metabolism, Dexamethasone, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/metabolism, Lenalidomide/administration & dosage, Humans, Immunologic Factors, Immunoglobulin Light-chain Amyloidosis, Lenalidomide, Retrospective Studies, Aged, Hematology, Middle Aged, Prognosis, Peptide Fragments, Progression-Free Survival, 3. Good health, EUTOPIA Alliance, Antineoplastic Agents, Hormonal/administration & dosage, Cohort studies, Drug Therapy, Combination, Female, Immunoglobulin Light Chains, Immunoglobulin Light Chains/immunology, Immunologic Factors/administration & dosage, Biomarkers, Follow-Up Studies

Access URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17685
https://pubmed.ncbi.nlm.nih.gov/34341985
https://www.openaccessrepository.it/record/103597
https://biblio.vub.ac.be/vubir/(ec473cb6-8b8a-4db6-9b4a-4b6f8fe30af4).html

Rationale for DPP-4 Inhibitors as Bridge or Dose-Sparing Therapy in Patients Using GLP-1 Receptor Agonists or Tirzepatide

Authors: Acanfora, Matteo

Subject Terms: Drug Therapy, Combination/classification, Diabetes, Drug Therapy, Combination/methods, Hyperglycemia/diagnosis, Diabetes Mellitus/pathology, Cardiovascular disease, Cardiovascular System, Diabetes Complications, Diabetes Mellitus/physiopathology, Cardiovascular system, Combination effect, Drug Combinations, Glucose, Cardiovascular diseases, Cardiovascular Diseases, Diabetes Mellitus, Drug Therapy, Combination

Counteraction of perforated cecum lesions in rats: effects of pentadecapeptide BPC 157, L-NAME and L-arginine

Authors: Drmić, Domagoj, Samara, Mariam, Vidović, Tinka, Malekinušić, Dominik, Antunović, Marko, Vrdoljak, Borna, Ruzman, Jelena, Milković Periša, Marija, Horvat Pavlov, Katarina, Jeyakumar, Jerusha, Seiwerth, Sven, Sikirić, Predrag

Contributors: University of Zagreb. University of Zagreb, School of Medicine

Source: World J Gastroenterol

Subject Terms: Male, 0301 basic medicine, vessels, L-arginine, Cecum/blood supply, BPC 157, NG-Nitroarginine Methyl Ester/therapeutic use, Wound Healing/drug effects, Cecum, 0303 health sciences, Basic Study, Proteins/pharmacology, Arginine/therapeutic use, 3. Good health, Kliničke medicinske znanosti, NG-Nitroarginine Methyl Ester, Treatment Outcome, Biomedicina i zdravstvo, Drug Therapy, Combination, Anti-Ulcer Agents/therapeutic use, L-NAME, perforated cecum, rats, Drug Therapy, Combination/methods, Arginine, Nitric Oxide, 03 medical and health sciences, Clinical Medical Sciences, Animals, Humans, NG-Nitroarginine Methyl Ester/pharmacology, Cecum/injuries, Biomedicine and Health Sciences, Rats, Wistar, Intestinal Perforation/drug therapy, Peptide Fragments/therapeutic use, Wound Healing, Peptide Fragments/pharmacology, Cecum/drug effects, Proteins, Anti-Ulcer Agents, Peptide Fragments, Rats, Disease Models, Animal, Proteins/therapeutic use, Intestinal Perforation, Nitric Oxide/metabolism, Anti-Ulcer Agents/pharmacology, Arginine/pharmacology

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/30622376
https://www.bib.irb.hr/981043
https://doi.org/10.3748/wjg.v24.i48.5462
https://www.wjgnet.com/1007-9327/full/v24/i48/5462.htm
https://doi.org/10.3748/wjg.v24.i48.5462
http://medlib.mef.hr/3286/1/drmic_d_et_al_rep_3286.pdf

Seventeen‐Year Nationwide Trends in Use of Long‐acting Bronchodilators and Inhaled Corticosteroids among Adults – A Danish Drug Utilization Study: A Danish Drug Utilization Study

Authors: Reilev, Mette, Pottegard, Anton, Davidsen, Jesper Romhild, Rasmussen, Lotte, Sondergaard, Jens, Laursen, Christian B., Henriksen, Daniel Pilsgaard

Source: Reilev, M, Pottegård, A, Davidsen, J R, Rasmussen, L, Søndergaard, J, Laursen, C B & Henriksen, D P 2018, 'Seventeen-Year Nationwide Trends in Use of Long-acting Bronchodilators and Inhaled Corticosteroids among Adults : A Danish Drug Utilization Study', Basic & Clinical Pharmacology & Toxicology, vol. 123, no. 1, pp. 58-64. https://doi.org/10.1111/bcpt.12978

Subject Terms: Adult, Male, Drug Prescriptions/statistics & numerical data, Combination/methods, Time Factors, Denmark, Drug Therapy, Combination/methods, Glucocorticoids/standards, Muscarinic Antagonists, Drug Prescriptions, Pulmonary Disease, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Muscarinic Antagonists/standards, Administration, Inhalation, 80 and over, Patient Compliance/statistics & numerical data, Humans, Glucocorticoids, Aged, Aged, 80 and over, Drug Utilization/statistics & numerical data, Registries/statistics & numerical data, Age Factors, Prescription Drugs/standards, Pneumonia, Middle Aged, Guideline Adherence/statistics & numerical data, Pulmonary Disease, Chronic Obstructive/drug therapy, Drug Utilization, Pneumonia/drug therapy, Bronchodilator Agents, 3. Good health, Bronchodilator Agents/standards, Inhalation, Chronic Obstructive/drug therapy, Administration, Practice Guidelines as Topic, Patient Compliance, Drug Therapy, Combination, Female, Guideline Adherence

File Description: application/pdf

Access URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.12978
https://pubmed.ncbi.nlm.nih.gov/29417739
https://portal.findresearcher.sdu.dk/da/publications/c684c8db-0636-4890-9043-f4bca66aab3e

Effect of Home Blood Pressure Monitoring on Patient’s Awareness and Goal Attainment Under Antihypertensive Therapy: The Factors Influencing Results in Anti-HypertenSive Treatment (FIRST) Study

Authors: Spirk, David, Noll, Sarah, Burnier, Michel, Rimoldi, Stefano, Noll, Georg, Sudano, Isabella

Contributors: University of Zurich, Sudano, Isabella

Source: Kidney & Blood Pressure Research, Vol 43, Iss 3, Pp 979-986 (2018)
Kidney & blood pressure research.-2018
Kidney & blood pressure research, vol. 43, no. 3, pp. 979-986

Subject Terms: Arterial hypertension, Male, Aged, Antihypertensive Agents/therapeutic use, Awareness, Biphenyl Compounds/therapeutic use, Blood Pressure/drug effects, Blood Pressure Monitoring, Ambulatory/methods, Drug Therapy, Combination/methods, Female, Goals, Humans, Hydrochlorothiazide/therapeutic use, Middle Aged, Self Care/standards, Switzerland, Tetrazoles/therapeutic use, Treatment Outcome, Antihypertensive therapy, Goal attainment, Home blood pressure monitoring, Tolerability, Tetrazoles, 610 Medicine & health, Blood Pressure, Dermatology, 2705 Cardiology and Cardiovascular Medicine, 03 medical and health sciences, 0302 clinical medicine, Diseases of the circulatory (Cardiovascular) system, Antihypertensive Agents, 2727 Nephrology, Biphenyl Compounds, Irbesartan, Blood Pressure Monitoring, Ambulatory, Diseases of the genitourinary system. Urology, 3. Good health, Self Care, Hydrochlorothiazide, RL1-803, RC666-701, 10209 Clinic for Cardiology, Drug Therapy, Combination, RC870-923

File Description: application/pdf; document.pdf - application/pdf

Access URL: https://www.karger.com/Article/Pdf/490687
https://pubmed.ncbi.nlm.nih.gov/29940594
https://doaj.org/article/79aec2d97a3d47118508629da37d95fc
https://sonar.ch/global/documents/156906
https://serval.unil.ch/resource/serval:BIB_BBBF0FB92D1B.P002/REF.pdf
https://serval.unil.ch/notice/serval:BIB_BBBF0FB92D1B
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_BBBF0FB92D1B2

Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non‐psychotic mania and non‐psychotic bipolar depression

Authors: Louise B. Bjørklund, Henriette T. Horsdal, Ole Mors, Christiane Gasse, Søren D. Østergaard

Source: Bjørklund, L B, Horsdal, H T, Mors, O, Gasse, C & Østergaard, S D 2017, 'Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non-psychotic mania and non-psychotic bipolar depression', Bipolar disorders, vol. 19, no. 6, pp. 505–512. https://doi.org/10.1111/bdi.12504

Subject Terms: Adult, Male, Bipolar Disorder, Bipolar Disorder/diagnosis, Denmark, Drug Therapy, Combination/methods, Antidepressive Agents/therapeutic use, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Humans, Registries, Age of Onset, 10. No inequality, Psychiatric Status Rating Scales, Anticonvulsants/therapeutic use, Middle Aged, Denmark/epidemiology, Antidepressive Agents, 3. Good health, Socioeconomic Factors, Anticonvulsants, Drug Therapy, Combination, Female, Antipsychotic Agents/therapeutic use, Antipsychotic Agents

Access URL: https://pubmed.ncbi.nlm.nih.gov/28593691

Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders: An Alley of Future Successful Treatment of Complex Disorders

Authors: Weiss, Andrea, Nowak-Sliwinska, Patrycja

Source: SLAS technology.-2017
SLAS TECHNOLOGY: Translating Life Sciences Innovation

Subject Terms: 0301 basic medicine, 0303 health sciences, top-down approach, Drug Therapy, Combination/methods, Antineoplastic Agents, Drug Screening Assays, Antitumor/methods, Neoplasms/drug therapy, 3. Good health, 03 medical and health sciences, Mass Screening/methods, Neoplasms, feedback system control, drug–drug interactions, Humans, Mass Screening, Drug Interactions, Drug Therapy, Combination, Drug Screening Assays, Antitumor, drug mixture optimization, synergistic drug combinations, Antineoplastic Agents/administration & dosage/pharmacology, response surface

File Description: application/pdf

Access URL: https://journals.sagepub.com/doi/pdf/10.1177/2472630316682338
https://pubmed.ncbi.nlm.nih.gov/28027446
https://sonar.ch/global/documents/280096

Defining the Place of Ezetimibe/Atorvastatin in the Management of Hyperlipidemia

Authors: Ferreira, AM, Marques da Silva, P

Source: American Journal of Cardiovascular Drugs. 17:169-181

Subject Terms: Cholesterol, HDL/blood, Simvastatin, Hyperlipidemias/drug therapy, HSM MED, Ezetimibe/administration & dosage, Anticholesteremic Agents, Hyperlipidemias/blood, Cholesterol, HDL, Drug Therapy, Combination/methods, Hyperlipidemias, Cholesterol, LDL, Ezetimibe, Simvastatin/administration & dosage, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Cholesterol, LDL/blood, 13. Climate action, Anticholesteremic Agents/administration & dosage, Atorvastatin, Humans, Drug Therapy, Combination, Atorvastatin Calcium/administration & dosage

Access URL: http://repositorio.chlc.min-saude.pt/bitstream/10400.17/2598/1/Am%20J%20Cardiovasc%20Drugs.pdf
https://pubmed.ncbi.nlm.nih.gov/27943172
http://hdl.handle.net/10400.17/2598

Does dexamethasone have a perineural mechanism of action? A paired, blinded, randomized, controlled study in healthy volunteers

Authors: Jæger, P, Grevstad, Jens Ulrik, Koscielniak-Nielsen, Z J, Sauter, A R, Sørensen, J K, Dahl, J B

Source: Jæger, P, Grevstad, U, Koscielniak-Nielsen, Z J, Sauter, A R, Sørensen, J K & Dahl, J B 2016, ' Does dexamethasone have a perineural mechanism of action? A paired, blinded, randomized, controlled study in healthy volunteers ', British Journal of Anaesthesia, vol. 117, no. 5, pp. 635-641 . https://doi.org/10.1093/bja/aew318

Subject Terms: Adult, Male, Time Factors, Nerve Block/methods, Amides/administration & dosage, Drug Therapy, Combination/methods, Pain, Dexamethasone, Young Adult, 03 medical and health sciences, Glucocorticoids/pharmacology, 0302 clinical medicine, Pain/drug therapy, Reference Values, Humans, Ropivacaine, Single-Blind Method, Anesthetics, Local, Glucocorticoids, Leg, Dexamethasone/pharmacology, Anesthetics, Local/administration & dosage, Nerve Block, Amides, Leg/innervation, Drug Therapy, Combination

Access URL: http://bjanaesthesia.org/article/S0007091217300223/pdf
https://pubmed.ncbi.nlm.nih.gov/27799178
https://pure.au.dk/portal/en/publications/9134e3d0-384b-4e2e-8137-e4650bf3859d
https://doi.org/10.1093/bja/aew318

VUV Luminescence Due to 5d - 4f Transitions in Gd3+ and Lu3+ Ions Doped into Fluoride Crystals

Authors: Makhov, V. N., Kirm, M., Vielhauer, S., Stryganyuk, G., Zimmerer, G.

Source: ECS transactions 11, 1-10 (2008). doi:10.1149/1.2929812
212th Electrochemical Society Meeting, Washington DC, USA, 2007-10-07-2007-10-12

Subject Terms: Adult, Male, Drug Therapy, Combination: methods, Epilepsy: drug therapy, Adolescent, rufinamide, 02 engineering and technology, Triazoles, 01 natural sciences, 0104 chemical sciences, 3. Good health, Triazoles: therapeutic use, Young Adult, Treatment Outcome, Double-Blind Method, Child, Preschool, Drug Evaluation, Humans, Female, Anticonvulsants, Longitudinal Studies, Child, 0210 nano-technology, Anticonvulsants: therapeutic use

Access URL: https://bib-pubdb1.desy.de/record/84831/files/Makhov_etal_ECT_transact11_d-f.pdf
https://bib-pubdb1.desy.de/record/84831
https://bib-pubdb1.desy.de/record/83456

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial: The CareRA trial

Authors: P Verschueren, D De Cock, L Corluy, R Joos, C Langenaken, V Taelman, F Raeman, I Ravelingien, K Vandevyvere, J Lenaerts, E Geens, P Geusens, J Vanhoof, A Durnez, J Remans, B Vander Cruyssen, E Van Essche, A Sileghem, G De Brabanter, J Joly, S Meyfroidt, K Van der Elst, R Westhovens, B Maeyaert, M Devinck, A Verbruggen, K de Vlam, M Coppens, P Volders, F Van Den Bosch

Contributors: Public Health Sciences

Source: Decock, D, Verschueren, P, De Cock, D, Corluy, L, Joos, R, Langenaken, C, Taelman, V, Raeman, F, Ravelingien, I, Vandevyvere, K, Lenaerts, J, Geens, E, Geusens, P, Vanhoof, J, Durnez, A, Remans, J, Vander Cruyssen, B, Van Essche, E, Sileghem, A, De Brabanter, G, Joly, J, Meyfroidt, S, Van der Elst, K & Westhovens, R 2015, 'Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial', Ann Rheum Dis, vol. 74, no. 1, pp. 27-34. https://doi.org/10.1136/annrheumdis-2014-205489

Subject Terms: Male, Combination/methods, early rheumatoid arthritis, PLACEBO-CONTROLLED TRIAL, Severity of Illness Index, DMARDs, Arthritis, Rheumatoid, DOUBLE-BLIND, 0302 clinical medicine, Antirheumatic Agents/*therapeutic use, Isoxazoles/*therapeutic use, TREATMENT STRATEGIES, Induction Chemotherapy, Middle Aged, 3. Good health, Arthritis, Rheumatoid/diagnosis/*drug therapy, Treatment Outcome, Antirheumatic Agents, Glucocorticoids/*therapeutic use, Drug Therapy, Combination, Female, Sulfasalazine/*therapeutic use, EARLY RA PATIENTS, Leflunomide, Prednisone/*therapeutic use, Adult, TARGET STRATEGY, Drug Therapy, Combination/methods, RADIOGRAPHIC PROGRESSION, Risk Assessment, methotrexate, Induction Chemotherapy/methods, 03 medical and health sciences, Drug Therapy, Early Medical Intervention, Humans, Glucocorticoids, Aged, Rheumatoid/diagnosis/*drug therapy, BIOLOGIC AGENTS, Methotrexate/*therapeutic use, TIGHT CONTROL, Arthritis, Isoxazoles, RANDOMIZED-TRIAL, Treatment, Sulfasalazine, Methotrexate, MODIFYING ANTIRHEUMATIC DRUGS, Prednisone

Access URL: https://ard.bmj.com/content/74/1/27.full.pdf
https://pubmed.ncbi.nlm.nih.gov/25359382
https://research.manchester.ac.uk/en/publications/0fec4a01-d77b-4835-b628-62e842db4d2b
https://doi.org/10.1136/annrheumdis-2014-205489
https://cris.maastrichtuniversity.nl/en/publications/f1551480-3c42-4c48-beb4-5486cd35f754
https://doi.org/10.1136/annrheumdis-2014-205489
https://research.manchester.ac.uk/en/publications/0fec4a01-d77b-4835-b628-62e842db4d2b
https://doi.org/10.1136/annrheumdis-2014-205489
http://www.ncbi.nlm.nih.gov/pubmed/25359382
https://biblio.vub.ac.be/vubir/(8c2be5c4-bea4-4a9b-9749-6bdcfdc64561).html

HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy

Authors: Carey, I, Bruce, M, Horner, M, Zen, Y, D'Antiga, L, Bansal, S, Vergani, D, Mieli-Vergani, G

Source: Carey, I, Bruce, M, Horner, M, Zen, Y, D'Antiga, L, Bansal, S, Vergani, D & Mieli-Vergani, G 2015, 'HBsAg plasma level kinetics : a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy', Journal of Viral Hepatitis, vol. 22, no. 4, pp. 441-452. https://doi.org/10.1111/jvh.12316

Subject Terms: Male, 0301 basic medicine, cccDNA, chronic hepatitis B, HBsAg levels, immunotolerant patients, precore mutations, Combination/methods, Hepatitis B, Chronic/drug therapy, Adolescent, Drug Therapy, Combination/methods, Chronic/drug therapy, Antiviral Agents, Plasma, 03 medical and health sciences, Hepatitis B, Chronic, Drug Therapy, DNA, Viral/analysis, Humans, Lamivudine/therapeutic use, Preschool, Child, Antiviral Agents/therapeutic use, 0303 health sciences, Hepatitis B Surface Antigens, Gene Expression Profiling, Interferon-alpha/therapeutic use, Interferon-alpha, DNA, Hepatitis B, Prognosis, Hepatitis B Surface Antigens/analysis, Plasma/chemistry, Immunohistochemistry, Liver/virology, 3. Good health, Treatment Outcome, Liver, Lamivudine, Child, Preschool, DNA, Viral, Drug Therapy, Combination, Female, Viral/analysis, Drug Monitoring, Drug Monitoring/methods, Biomarkers/blood, Biomarkers

File Description: application/pdf; application/mspowerpoint

Access URL: https://kclpure.kcl.ac.uk/portal/files/56359971/HBsAg_plasma_level_kinetics.pdf
https://pubmed.ncbi.nlm.nih.gov/25278170

A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial: the EMPIRE trial

Authors: Nam, JL, Villeneuve, E, Hensor, EM, Wakefield, RJ, Conaghan, PG, Green, MJ, Gough, A, Quinn, M, Reece, R, Cox, SR, Buch, MH, van der Heijde, DM, Emery, P

Source: Nam, J L, Villeneuve, E, Hensor, E M A, Wakefield, R J, Conaghan, P G, Green, M J, Gough, A, Quinn, M, Reece, R, Cox, S R, Buch, M H, van der Heijde, D M & Emery, P 2014, 'A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis : the EMPIRE trial', Annals of the rheumatic diseases, vol. 73, no. 6, pp. 1027-36. https://doi.org/10.1136/annrheumdis-2013-204882

Subject Terms: Male, Combination/methods, Receptors, Tumor Necrosis Factor/therapeutic use, Antirheumatic Agents/therapeutic use, DMARDs (biologic), Receptors, Tumor Necrosis Factor, Etanercept, Anti-TNF, Arthritis, Rheumatoid, 0302 clinical medicine, Early Rheumatoid Arthritis, Rheumatoid, Receptors, 80 and over, Arthritis/drug therapy, 10. No inequality, Synovitis/drug therapy, Aged, 80 and over, Synovitis, Remission Induction, Induction Chemotherapy, Middle Aged, 3. Good health, Treatment Outcome, Arthritis, Rheumatoid/drug therapy, Antirheumatic Agents, Combination, Drug Therapy, Combination, Female, Rheumatoid Factor/immunology, Autoantibodies/immunology, Adult, Adolescent, Methotrexate/therapeutic use, Tumor Necrosis Factor/therapeutic use, Drug Therapy, Combination/methods, Immunoglobulin G/therapeutic use, Early Medical Intervention/methods, Rheumatoid/drug therapy, Induction Chemotherapy/methods, Young Adult, 03 medical and health sciences, Drug Therapy, Double-Blind Method, Rheumatoid Factor, Early Medical Intervention, Humans, Aged, Autoantibodies, Arthritis, Remission Induction/methods, Methotrexate, Immunoglobulin G, Tumor Necrosis Factor

Access URL: https://pubmed.ncbi.nlm.nih.gov/24618266
https://hdl.handle.net/1887/105884
https://eprints.whiterose.ac.uk/id/eprint/86936/

Recombinant Human Activated Protein C for Adults with Septic Shock. A Randomized Controlled Trial

Authors: Annane, Djillali, Timsit, Jean-François, Mégarbane, Bruno, Martin, Claude, Misset, Benoit, Mourvillier, Bruno, Siami, Shidasp, Chagnon, Jean-Luc, Constantin, Jean-Michel, Petitpas, Franck, Souweine, Bertrand, Amathieu, Roland, Forceville, Xavier, Charpentier, Claire, Tesnière, Antoine, Chastre, Jean, Bohe, Julien, Colin, Gwenhael, Cariou, Alain, Renault, Alain, Brun-Buisson, Christian, Bellissant, Eric

Contributors: Mégarbane, Bruno

Source: American Journal of Respiratory and Critical Care Medicine. 187:1091-1097

Subject Terms: Male, 0301 basic medicine, Anesthésie & soins intensifs, Hydrocortisone, Anti-Infective Agents/therapeutic use, Anti-Inflammatory Agents, Drug Therapy, Combination/methods, Anti-Inflammatory Agents/therapeutic use, Sciences de la santé humaine, Safety-Based Drug Withdrawals, 03 medical and health sciences, Anti-Infective Agents, Double-Blind Method, Fludrocortisone/therapeutic use, Protein C/therapeutic use, Recombinant Proteins/therapeutic use, Humans, Human health sciences, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Hydrocortisone/therapeutic use, Anesthesia & intensive care, Middle Aged, Shock, Septic, Recombinant Proteins, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, [SDV.TOX] Life Sciences [q-bio]/Toxicology, Treatment Outcome, Shock, Septic/drug therapy, Fludrocortisone, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Drug Therapy, Combination, Female, Protein C

Access URL: https://pubmed.ncbi.nlm.nih.gov/23525934

Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains

Authors: Cencig, Sabrina, Coltel, Nicolas, Truyens, Carine, Carlier, Yves

Source: International Journal of Antimicrobial Agents; Vol 40
International journal of antimicrobial agents, 40 (6

Subject Terms: 0301 basic medicine, Trypanosoma cruzi, Combination -- methods, Drug Therapy, Combination -- methods, Parasitemia, Real-Time Polymerase Chain Reaction, Parasite Load, Trypanocidal Agents -- administration & dosage, Mice, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Chagas Disease -- drug therapy, Amphotericin B, Amphotericin B -- administration & dosage, Animals, Chagas Disease, Parasitemia -- drug therapy, Posaconazole, Triazoles -- administration & dosage, Inbred BALB C, Mice, Inbred BALB C, DNA, Protozoan -- blood, Animal, DNA, Sciences bio-médicales et agricoles, DNA, Protozoan, Triazoles, Trypanocidal Agents, 3. Good health, Nitroimidazoles -- administration & dosage, Protozoan -- blood, Disease Models, Animal, Treatment Outcome, Nifurtimox -- administration & dosage, Nitroimidazoles, Disease Models, Benznidazole, Trypanosoma cruzi -- drug effects -- isolation & purification, Drug Therapy, Combination, Female, Nifurtimox, AmBisome®, Cure

File Description: 1 full-text file(s): application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/23063742
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/159784
https://dipot.ulb.ac.be/dspace/bitstream/2013/159784/8/Elsevier_145104.pdf

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy

Authors: Maisonobe, Jacques-Antoine, Garcia, Camilo, Necib, Hatem, Vanderlinden, Bruno, Hendlisz, Alain, Flamen, Patrick, Buvat, Irène

Contributors: Buvat, Irène, Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC (UMR_8165)), Université Paris-Sud - Paris 11 (UP11)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Institut Jules Bordet Bruxelles, Faculté de Médecine Bruxelles (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)

Source: Eur J Nucl Med Mol Imaging
European journal of nuclear medicine and molecular imaging, 40 (2

Subject Terms: Contrast Media -- pharmacology, Adult, Male, Positron-Emission Tomography -- methods, Adolescent, Combination -- methods, Contrast Media, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine, Drug Therapy, Combination -- methods, Treatment response, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, [SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, [SDV.CAN] Life Sciences [q-bio]/Cancer, Models, Classification performances, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Humans, Neoplasm Metastasis, Imagerie médicale, radiologie, tomographie, Imagerie médicale, radiologie, Aged, Aged, 80 and over, Models, Statistical, Reproducibility of Results, Statistical, Middle Aged, Colorectal cancer, tomographie, SUV, 3. Good health, ROC Curve, Radiology Nuclear Medicine and imaging, Colorectal Neoplasms -- drug therapy -- pathology, Positron-Emission Tomography, Partial volume effect, FDG PET, Original Article, Drug Therapy, Combination, Female, Colorectal Neoplasms, Glycolysis

File Description: 1 full-text file(s): application/pdf

Access URL: https://link.springer.com/content/pdf/10.1007%2Fs00259-012-2274-x.pdf
https://pubmed.ncbi.nlm.nih.gov/23151911
https://dipot.ulb.ac.be/dspace/bitstream/2013/168465/4/doi_152095.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168465
https://hal.science/hal-02401431v1
https://doi.org/10.1007/s00259-012-2274-x

Local Structure of Pulse Plated Ni Rich Ni-Zn Alloys and Its Effect on the Electrocatalytic Activity in the Hydrogen Evolution Reaction

Authors: Goransson, G., Peter, M., Franc, J., Petrykin, V., Ahlberg, E., Krtil, P.

Source: Journal of the Electrochemical Society 159, D555-D562 (2012). doi:10.1149/2.047209jes

Subject Terms: Adult, Male, Drug Therapy, Combination: methods, Epilepsy: drug therapy, Adolescent, rufinamide, 02 engineering and technology, Triazoles, Triazoles: therapeutic use, Young Adult, Treatment Outcome, Double-Blind Method, Child, Preschool, 0202 electrical engineering, electronic engineering, information engineering, Drug Evaluation, Humans, Female, Anticonvulsants, Longitudinal Studies, Child, 0210 nano-technology, Anticonvulsants: therapeutic use

Access URL: https://bib-pubdb1.desy.de/record/140953

VUV Spectroscopy of Ca3Sc2Si3O12:Pr3+: Scintillator Optimization by Co-Doping with Mg2+

Authors: Ivanovskikh, K. V., Meijerink, A., Piccinelli, F., Speghini, A., Ronda, C., Bettinelli, M.

Source: ECS journal of solid state science and technology 1, R127-R130 (2012). doi:10.1149/2.009205jss

Subject Terms: Adult, Male, Drug Therapy, Combination: methods, Epilepsy: drug therapy, Adolescent, rufinamide, 02 engineering and technology, Triazoles, 01 natural sciences, 3. Good health, 0104 chemical sciences, Triazoles: therapeutic use, Young Adult, Treatment Outcome, Double-Blind Method, Child, Preschool, Drug Evaluation, Humans, Female, Anticonvulsants, Longitudinal Studies, Child, 0210 nano-technology, Anticonvulsants: therapeutic use

Access URL: https://bib-pubdb1.desy.de/record/141027